18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial - The Lancet
Por um escritor misterioso
Descrição
Improvements in Prostate Cancer Management: Focus on Imaging and Treatment - European Medical Journal
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
Frontiers Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial
Imaging in Prostate Cancer: An Update on a Rapidly Changing Space
Cancers, Free Full-Text
Cancers, Free Full-Text
Clinical practice in prostate PET imaging - Sean J. Huls, Brian Burkett, Eric Ehman, Val J. Lowe, Rathan M. Subramaniam, A. Tuba Kendi, 2023
Frontiers Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
Between the Lines Podcast: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
Axumin LOCATE Trial Results Axumin® (fluciclovine F 18) Injection
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial
de
por adulto (o preço varia de acordo com o tamanho do grupo)